{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T23:36:00Z","timestamp":1721950560966},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.mehy.2016.12.007","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T17:02:13Z","timestamp":1482166933000},"page":"40-44","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["MEN1 and microRNAs: The link between sporadic pituitary, parathyroid and adrenocortical tumors?"],"prefix":"10.1016","volume":"99","author":[{"given":"Z.","family":"Nagy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.M.","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.K.","family":"Grolmusz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Perge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Igaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pat\u00f3cs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Igaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2016.12.007_b0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.mehy.2016.12.007_b0010","first-page":"2172","article-title":"Epid\u00e9miologie des ad\u00e9nomes hypophysaires: \u00c9tude dans une agglom\u00e9ration urbaine de Suisse","volume":"5","author":"Fontana","year":"2009","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.mehy.2016.12.007_b0015","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2006-1668","article-title":"High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium","volume":"91","author":"Daly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2016.12.007_b0020","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10143-014-0525-y","article-title":"Invasive adenoma and pituitary carcinoma: a SEER database analysis","volume":"37","author":"Hansen","year":"2014","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.mehy.2016.12.007_b0025","first-page":"1066","article-title":"Pituitary carcinoma: a clinicopathological review","volume":"56","author":"Scheithauer","year":"2005","journal-title":"Neurosurgery"},{"key":"10.1016\/j.mehy.2016.12.007_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.wneu.2016.04.112","article-title":"Prolactin-secreting pituitary carcinoma with dural metastasis: diagnosis, treatment, and future directions","author":"Seltzer","year":"2016","journal-title":"World Neurosurg"},{"key":"10.1016\/j.mehy.2016.12.007_b0035","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/mt.2011.48","article-title":"Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice","volume":"19","author":"Trang","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.mehy.2016.12.007_b0040","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ando.2015.03.003","article-title":"Parathyroid carcinoma: challenges in diagnosis and treatment","volume":"76","author":"Betea","year":"2015","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.mehy.2016.12.007_b0045","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ecl.2015.02.005","article-title":"Adrenal incidentalomas","volume":"44","author":"Ioachimescu","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.mehy.2016.12.007_b0050","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"key":"10.1016\/j.mehy.2016.12.007_b0055","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00268-002-6492-4","article-title":"Adrenal involvement in multiple endocrine neoplasia type 1","volume":"26","author":"Langer","year":"2002","journal-title":"World J Surg"},{"key":"10.1016\/j.mehy.2016.12.007_b0060","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2016.12.007_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000345666","article-title":"Multiple endocrine neoplasia type 1","volume":"41","author":"Agarwal","year":"2013","journal-title":"Front Horm Res"},{"key":"10.1016\/j.mehy.2016.12.007_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4419-1664-8_1","article-title":"MEN1 clinical background","volume":"668","author":"Igaz","year":"2009","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.mehy.2016.12.007_b0075","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejso.2008.06.006","article-title":"MicroRNAs: key players in carcinogenesis and novel therapeutic targets","volume":"35","author":"Mirnezami","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.mehy.2016.12.007_b0080","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11102-010-0268-x","article-title":"MicroRNA profile indicates downregulation of the TGF\u03b2 pathway in sporadic non-functioning pituitary adenomas","volume":"14","author":"Butz","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.mehy.2016.12.007_b0085","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.ajpath.2011.07.002","article-title":"Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas","volume":"179","author":"Cheunsuchon","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.mehy.2016.12.007_b0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1227\/NEU.0000000000000369","article-title":"MicroRNAs as biomarkers in pituitary tumors","volume":"75","author":"Di Ieva","year":"2014","journal-title":"Neurosurgery"},{"key":"10.1016\/j.mehy.2016.12.007_b0095","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s12020-015-0555-4","article-title":"Epigenetic alterations in human parathyroid tumors","volume":"49","author":"Verdelli","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.mehy.2016.12.007_b0100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/ERC-09-0134","article-title":"Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue","volume":"17","author":"Corbetta","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.mehy.2016.12.007_b0105","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1530\/ERC-11-0082","article-title":"The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma","volume":"18","author":"\u00d6zata","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.mehy.2016.12.007_b0110","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1677\/ERC-09-0096","article-title":"Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis","volume":"16","author":"T\u00f6mb\u00f6l","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.mehy.2016.12.007_b0115","doi-asserted-by":"crossref","first-page":"7684","DOI":"10.1158\/1078-0432.CCR-09-1587","article-title":"MiR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer","volume":"15","author":"Soon","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.mehy.2016.12.007_b0120","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1210\/me.2012-1220","article-title":"Minireview: miRomics in endocrinology: a novel approach for modeling endocrine diseases","volume":"27","author":"Szab\u00f3","year":"2013","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.mehy.2016.12.007_b0125","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.tibs.2013.05.005","article-title":"Menin: a scaffold protein that controls gene expression and cell signaling","volume":"38","author":"Matkar","year":"2013","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.mehy.2016.12.007_b0130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nrendo.2014.181","article-title":"Genetic mutations in sporadic pituitary adenomas\u2014what to screen for?","volume":"11","author":"Lecoq","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.mehy.2016.12.007_b0135","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)","volume":"386","author":"Thakker","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.mehy.2016.12.007_b0140","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1530\/EJE-12-0327","article-title":"MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism","volume":"168","author":"Alvelos","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.mehy.2016.12.007_b0145","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2012-1743","article-title":"Identification of somatic mutations in parathyroid tumors using whole-exome sequencing","volume":"97","author":"Cromer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2016.12.007_b0150","doi-asserted-by":"crossref","first-page":"E1995","DOI":"10.1210\/jc.2012-2303","article-title":"Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas","volume":"97","author":"Newey","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2016.12.007_b0155","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/EJE-12-0763","article-title":"Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don\u2019t forget MEN1 genetic analysis","volume":"168","author":"Cuny","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.mehy.2016.12.007_b0160","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assi\u00e9","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.mehy.2016.12.007_b0165","doi-asserted-by":"crossref","DOI":"10.1111\/joim.12458","article-title":"Molecular genetics and epigenetics of nonfamilial (sporadic) parathyroid tumours","author":"Westin","year":"2016","journal-title":"J Intern Med"},{"key":"10.1016\/j.mehy.2016.12.007_b0170","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ecl.2015.02.004","article-title":"The genetics of adrenocortical tumors","volume":"44","author":"Espiard","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.mehy.2016.12.007_b0175","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2015.10.076","article-title":"Expression pattern of the Hedgehog signaling pathway in pituitary adenomas","volume":"611","author":"Yavropoulou","year":"2016","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mehy.2016.12.007_b0180","doi-asserted-by":"crossref","first-page":"10011","DOI":"10.1007\/s13277-014-1921-1","article-title":"Downregulation of tumor suppressor menin by miR-421 promotes proliferation and migration of neuroblastoma","volume":"35","author":"Li","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.mehy.2016.12.007_b0185","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3892\/mmr.2014.2361","article-title":"MicroRNA-802 promotes lung carcinoma proliferation by targeting the tumor suppressor menin","volume":"10","author":"Wang","year":"2014","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.mehy.2016.12.007_b0190","doi-asserted-by":"crossref","first-page":"562","DOI":"10.18632\/oncoscience.79","article-title":"Menin-mediated regulation of miRNA biogenesis uncovers the IRS2 pathway as a target for regulating pancreatic beta cells","volume":"1","author":"Gurung","year":"2014","journal-title":"Oncoscience"},{"key":"10.1016\/j.mehy.2016.12.007_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0039767","article-title":"The negative feedback-loop between the Oncomir mir-24-1 and Menin modulates the men1 tumorigenesis by mimicking the \u201cKnudson\u2019s second hit\u201d","volume":"7","author":"Luzi","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2016.12.007_b0200","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1039\/C6MB00118A","article-title":"An autoregulatory network between menin and pri-miR-24-1 is required for the processing of its specific modulator miR-24-1 in BON1 cells","volume":"12","author":"Luzi","year":"2016","journal-title":"Mol BioSyst"},{"key":"10.1016\/j.mehy.2016.12.007_b0205","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2016.12.007_b0210","doi-asserted-by":"crossref","first-page":"E84","DOI":"10.1152\/ajpendo.00542.2013","article-title":"MiR-24 regulates menin in the endocrine pancreas","volume":"307","author":"Vijayaraghavan","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.mehy.2016.12.007_b0215","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12672-010-0041-7","article-title":"CTNNB1 gene mutations, pituitary transcription factors, and microRNA expression involvement in the pathogenesis of adamantinomatous craniopharyngiomas","volume":"1","author":"Campanini","year":"2010","journal-title":"Horm Cancer"},{"key":"10.1016\/j.mehy.2016.12.007_b0220","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/HYPERTENSIONAHA.113.01102","article-title":"MicroRNA-24 is a novel regulator of aldosterone and cortisol production in the human adrenal cortex","volume":"62","author":"Robertson","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.mehy.2016.12.007_b0225","doi-asserted-by":"crossref","first-page":"10287","DOI":"10.1007\/s13277-014-2316-z","article-title":"MicroRNA-142-3p, a novel target of tumor suppressor menin, inhibits osteosarcoma cell proliferation by down-regulation of FASN","volume":"35","author":"Yang","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.mehy.2016.12.007_b0230","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1210\/en.2011-1285","article-title":"ACTH-dependent regulation of MicroRNA as endogenous modulators of glucocorticoid receptor expression in the adrenal gland","volume":"153","author":"Riester","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.mehy.2016.12.007_b0235","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.steroids.2010.04.008","article-title":"Expression of glucocorticoid receptor isoforms in human adrenocortical adenomas","volume":"75","author":"Boyle","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/j.mehy.2016.12.007_b0240","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00018-012-1080-8","article-title":"The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis","volume":"70","author":"Benetatos","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.mehy.2016.12.007_b0245","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12020-010-9346-0","article-title":"MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas","volume":"38","author":"Stilling","year":"2010","journal-title":"Endocrine"},{"key":"10.1016\/j.mehy.2016.12.007_b0250","article-title":"Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1","volume":"97","author":"D\u2019Angelo","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2016.12.007_b0255","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1530\/EJE-13-0817","article-title":"MicroRNA expression patterns associated with hyperfunctioning and non-hyperfunctioning phenotypes in adrenocortical adenomas","volume":"170","author":"Vel\u00e1zquez-Fern\u00e1ndez","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.mehy.2016.12.007_b0260","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1530\/ERC-13-0051","article-title":"Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients","volume":"20","author":"Chabre","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.mehy.2016.12.007_b0265","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ejca.2006.01.022","article-title":"SF-1 overexpression in childhood adrenocortical tumours","volume":"42","author":"Pianovski","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.mehy.2016.12.007_b0270","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1158\/0008-5472.CAN-09-3970","article-title":"Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by MicroRNA in childhood adrenocortical tumors","volume":"70","author":"Doghman","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2016.12.007_b0275","doi-asserted-by":"crossref","first-page":"6559","DOI":"10.1158\/1078-0432.CCR-14-1784","article-title":"MiR-154\u2217 and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer","volume":"20","author":"Gururajan","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.mehy.2016.12.007_b0280","doi-asserted-by":"crossref","first-page":"e68753","DOI":"10.1371\/journal.pone.0068753","article-title":"MiR-379 regulates cyclin B1 expression and is decreased in breast cancer","volume":"8","author":"Khan","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2016.12.007_b0285","doi-asserted-by":"crossref","first-page":"e37361","DOI":"10.1371\/journal.pone.0037361","article-title":"Identification of microRNAs inhibiting TGF-beta-induced IL-11 production in bone metastatic breast cancer cells","volume":"7","author":"Pollari","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2016.12.007_b0290","doi-asserted-by":"crossref","first-page":"8584","DOI":"10.1074\/jbc.M112.341958","article-title":"Impaired transforming growth factor-beta (TGF-beta) transcriptional activity and cell proliferation control of a menin in-frame deletion mutant associated with multiple endocrine neoplasia type 1 (MEN1)","volume":"287","author":"Canaff","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2016.12.007_b0295","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1055\/s-2005-870152","article-title":"Menin and TGF-beta superfamily member signaling via the Smad pathway in pituitary, parathyroid and osteoblast","volume":"37","author":"Hendy","year":"2005","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.mehy.2016.12.007_b0300","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1158\/0008-5472.CAN-09-1601","article-title":"Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells","volume":"69","author":"Ragazzon","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2016.12.007_b0305","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.prp.2013.06.002","article-title":"Expression of Wnt and TGF-beta pathway components and key adrenal transcription factors in adrenocortical tumors: association to carcinoma aggressiveness","volume":"209","author":"Parviainen","year":"2013","journal-title":"Pathol Res Pract"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698771630367X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698771630367X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T14:48:08Z","timestamp":1568645288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030698771630367X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":61,"alternative-id":["S030698771630367X"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2016.12.007","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MEN1 and microRNAs: The link between sporadic pituitary, parathyroid and adrenocortical tumors?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2016.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}